Replies to post #15115 on RespireRx Pharmaceuticals Inc (RSPI)

[atheroprevent]

asuhowe, I have invested in 4 companies, with great potential for growth, bought by BP during the past decade. I added or retained a positon a position in ther acquiring BPs.

Subsequently I have only a short term CD equivalent return from the aquiring BPs because the dilutional effect dispersing the earning benefit. In one, the benefit of acquisition has yet to contribute to income(6 years post acquisition).

With COR, RD might contribute to BP income in five years, but the broader CNS indications are still 10 years from prescription sales.

I was tempted to sell my interest many times before acquisition, but stayed because I felt my initial reason for investment remained valid. With Cor I join everyone else who invested too early. The risk/reward is keeping me in the game. JMHO